VIVEbiotech is a GMP Contract Development and Manufacturing Organization (CDMO) specialized in Lentiviral vectors. VIVE is focused on the manufacture of Research, Preclinical toxicology and GMP-grade lentiviral vectors. Sealed as Excellence Centre by European Union, VIVEbiotech is currently working with Companies based both in Europe and USA being our main interest adapting to Customer requirements considering also planning and timelines related issues. Importanly, VIVEbiotech is also developing its Lentiviral vector related technology, LENTISOMA. LENTISOMA´s technology is a non-Integrative replicative episomal lentiviral vector .